Trial Information

Summary: A clinical research trial is underway evaluating the effectiveness of an investigational medication in the hope that it will improve the memory and other cognitive functions of people with Alzheimer’s disease.

A six-month double-blind, placebo-controlled trial evaluating the investigational medication in people with Alzheimer’s disease who are only taking a medication called Aricept® (donepezil) for their Alzheimer’s disease.

Please visit our website for more information on this trial: www.trialforAD.com

Click http://www.clinicaltrials.gov/ct2/show/NCT00672945?term=NCT00672945&rank=1 to see this trial’s page on clinicaltrials.gov

Your loved one may qualify if he or she:

• Is between 50 and 90 years old
• Has a diagnosis of probable Alzheimer’s disease
• Has been on a stable dose of Aricept® (donepezil) for Alzheimer’s disease for at least three months
• Has no history of cancer within the past three years
• Is able to attend all office visits
• Lives with, or spends substantial periods of time with, a regular caregiver who is willing to attend all trial visits, oversee compliance, and report on the loved one’s status

If you would like to learn more about participating in this study, please send an e-mail message using the form below.